Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2013 1
2014 1
2018 1
2019 1
2020 1
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy.
Gutwillig A, Santana-Magal N, Farhat-Younis L, Rasoulouniriana D, Madi A, Luxenburg C, Cohen J, Padmanabhan K, Shomron N, Shapira G, Gleiberman A, Parikh R, Levy C, Feinmesser M, Hershkovitz D, Zemser-Werner V, Zlotnik O, Kroon S, Hardt WD, Debets R, Reticker-Flynn NE, Rider P, Carmi Y. Gutwillig A, et al. Among authors: rasoulouniriana d. Elife. 2022 Sep 20;11:e80315. doi: 10.7554/eLife.80315. Elife. 2022. PMID: 36124553 Free PMC article.
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors.
Rasoulouniriana D, Santana-Magal N, Gutwillig A, Farhat-Younis L, Tal L, Amar S, Milyavsky M, Muddineni SSNA, Solomon N, Shpilt H, Dotan S, Pilpel N, Waskow C, Feinmesser M, Rider P, Carmi Y. Rasoulouniriana D, et al. Cancer Immunol Res. 2023 Jun 2;11(6):792-809. doi: 10.1158/2326-6066.CIR-22-0423. Cancer Immunol Res. 2023. PMID: 37070661 Free PMC article.
Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy.
Santana-Magal N, Farhat-Younis L, Gutwillig A, Gleiberman A, Rasoulouniriana D, Tal L, Netanely D, Shamir R, Blau R, Feinmesser M, Zlotnik O, Gutman H, Linde IL, Reticker-Flynn NE, Rider P, Carmi Y. Santana-Magal N, et al. Among authors: rasoulouniriana d. Cancer Res. 2020 May 15;80(10):1942-1956. doi: 10.1158/0008-5472.CAN-19-2944. Epub 2020 Mar 3. Cancer Res. 2020. PMID: 32127354
11 results